CoreAge Rx vs Mondae
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Mondae head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 76 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Mondae a bad call — it's best for cash-pay patients willing to confirm the exact plan total and billing interval before enrolling. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Mondae |
|---|---|---|
| Brief Score | 94/100 (A) | 76/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm current price Earlier listing: $87 per 28-day cycle. Current homepage and product-page prices conflict. Full price detailsCompounded semaglutide offered. Current medication quote unknown; earlier observed $87/mo on a 28-day cycle; current homepage and product-page amounts differ |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm current price Earlier listing: $126 per 28-day cycle. Current homepage and product-page prices conflict. Full price detailsCompounded tirzepatide offered. Current medication quote unknown; earlier observed $126/mo on a 28-day cycle; current homepage and product-page amounts differ |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises all 50 states; medication availability requires clinician and pharmacy confirmation |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Mondae: Public starting prices differ between the homepage and treatment pages. Confirm the medication, plan total, billing interval and renewal terms before relying on a monthly equivalent.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.